SpiritIndia.com

West Nile Virus :: DCHHS confirms second human case of West Nile Virus

Dallas County Health and Human Services has confirmed its second human case of West Nile virus for the 2007 season. The patient, residing in zip code 75206, has been diagnosed with West Nile Encephalitis and is recovering. DCHHS previously reported a case of West Nile fever diagnosed in a patient residing in zip code 75104. For medical confidentiality and personal privacy reasons, DCHHS is not providing additional information. DCHHS has notified the City of Dallas.

Heart Attack :: Coordinated care means faster treatment for rural heart attack patients

Heart attack patients as far as 150 miles away from a 24-hour emergency heart care center were able to receive treatment for blocked arteries within or faster than current recommended time frames, according to a study published in Circulation: Journal of the American Heart Association.

West Nile Virus :: Tests confirm first human case of West Nile virus in Pennsylvania

State Health Secretary Dr. Calvin B. Johnson today reported this year?s first confirmed human case of West Nile virus in Pennsylvania. The individual, a 56-year-old Clearfield County man, is recovering and has been discharged from the hospital.

Tuberculosis :: TB vaccine could provide improved protection against tuberculosis

Using a novel approach, researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a prototype vaccine against tuberculosis (TB) that works better in animal models than the only TB vaccine now available. In this era of multi-drug resistant TB and growing numbers of people with active TB due to coinfection with HIV, the advance could herald a needed breakthrough against one of the world?s leading killers.

Contact Lens :: Alert on Advanced Medical Optics Complete MoisturePlus Multipurpose Contact Lens Solution

FDA announced that many consumers may not be aware of the May 2007 recall of Complete MoisturePlus Multipurpose Contact Lens Solution manufactured by Advanced Medical Optics (AMO) and continue to use the recalled product.

Bipolar Disorder :: Wake-up pill under study to treat patients with bipolar disorder

A preliminary study of 85 patients with bipolar disorder shows that a drug used to treat patients with sleep disorders might also control the depressive symptoms associated with bipolar disorder. At least 44 percent of the participants in the study reported improved symptoms, a noteworthy improvement for a disorder in which new treatments are needed, according to the study’s author, Mark Frye, M.D., director of the Mayo Clinic Mood Disorders Clinic and Research Program.

Smoking :: MayoClinic.com launches new quit smoking center

Smoking-related diseases claim an estimated 438,000 American lives each year, including those affected indirectly, such as babies born prematurely due to prenatal maternal smoking and victims of secondhand exposure to tobacco’s carcinogens. Beating nicotine dependence is one of the best things individuals can do for their health.

Uterine Fibroid :: Ultrasound treatment of uterine fibroid tumors provides long term symptom relief

A noninvasive, outpatient treatment for noncancerous uterine tumors provides sustained relief from symptoms, according to a new Mayo Clinic led collaborative study.

Healthcare :: Mayo Clinic Podcasts Offer In-Depth Discussion on Diseases, Conditions

Mayo Clinic is launching a series of new free audio podcasts so people can learn more about diseases or conditions that interest them through in-depth discussions with Mayo Clinic experts.

Botulism :: No name french cut green beans may contain dangerous bacteria

The Canadian Food Inspection Agency (CFIA) and Loblaws Inc. are warning the public not to consume the No Name French Cut Green Beans described below because the product may be contaminated with Clostridium botulinum. Toxins produced by this bacteria may cause botulism, a life-threatening illness.